Elisabet Rossell

Title: Elisabet Rossell: Innovator in Endometrial Cancer Detection

Introduction

Elisabet Rossell is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medical diagnostics, particularly in the detection of endometrial cancer. Her innovative work has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Elisabet Rossell holds a patent for her invention titled "Markers for Endometrial Cancer." This invention is based on the discovery that specific biomarkers, including ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN, are differentially expressed in samples from patients with endometrial cancer compared to control samples. These biomarkers demonstrate excellent sensitivity and specificity, making them valuable for detecting endometrial cancer. Furthermore, the correlation between the expression levels of these biomarkers in tumor tissue and uterine fluid samples enhances their robustness in clinical applications.

Career Highlights

Elisabet Rossell is currently associated with Geadic Biotec, a company focused on advancing biotechnological solutions. Her work at Geadic Biotec emphasizes the importance of innovative research in the medical field, particularly in cancer diagnostics.

Collaborations

Elisabet has collaborated with notable colleagues, including Miguel Abal Posada and Andreas Doll. These partnerships have contributed to the advancement of her research and the development of her patented technologies.

Conclusion

Elisabet Rossell's contributions to the field of endometrial cancer detection through her innovative biomarkers represent a significant advancement in medical diagnostics. Her work has the potential to enhance early detection and improve patient outcomes in the fight against cancer.